Delivery Order SPE2DB24D2205-SPE2DB25FEBGM

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $51K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is a Delivery Order valued at $3,652.86 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of "VELSIPITY 2 MG TABLET 30S", a prescription medication, with a period of performance through August 2024. This award is not set aside for any specific business category. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,456.69, is a Firm Fixed Price Delivery Order for "VELSIPITY 2 MG TABLET 30S" with an ultimate completion date of April 2, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,564.20 firm fixed-price delivery order contract is for the supply of the pharmaceutical product "VELSIPITY 2 MG TABLET 30S". The contract is not designated as a set-aside and serves as a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,994.68 firm fixed-price delivery order is for the supply of 4566719487 VELSIPITY 2 MG TABLET 30S, with a completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567603299 ! VELSIPITY 2 MG TABLET 30S. The contract, valued at $18,358.24, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation, indicating open competition. The contract has an ultimate completion date of March 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VELSIPITY 2 MG TABLET 30S. The contract has a ceiling value of $14,545.61 and a completion date of February 20, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $45,219.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, and the ultimate completion date is April 21, 2025. The contract includes the supply of 4567967392 VELSIPITY 2 MG TABLET 30S, a pharmaceutical product. The award is not designated as a set-aside contract,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,274.58 firm-fixed-price delivery order contract is for the supply of 4567375898 ! VELSIPITY 2 MG TABLET 30S to support military healthcare programs. The contract has an ultimate completion date of February 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,628.83, is for the delivery of 4567012430 ! VELSIPITY 2 MG TABLET 30S. It is a firm fixed-price delivery order contract with a completion date of January 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp for the delivery of 4566594734 ! VELSIPITY 2 MG TABLET 30S. The firm-fixed-price contract, valued at $30,429.72, has an ultimate completion date of December 4, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBGM
    Delivery Order

This federal contract award, valued at $51,025.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of the medication "VELSIPITY 2 MG TABLET 30S" and is a Firm Fixed Price contract type. The period of performance extends through April 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The current award does not utilize a set-aside designation, indicating open competition.

Generated 7/21/25, 7:38 PM